Linsitinib
Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor (IGF-1R). This prevents tumor cell proliferation and induces tumor cell apoptosis. Linsitinib was granted orphan drug designation for adrenocortical carcinoma in March 2012.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Linsitinib
Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor (IGF-1R). This prevents tumor cell proliferation and induces tumor cell apoptosis. Linsitinib was granted orphan drug designation for adrenocortical carcinoma in March 2012.
has abstract
Linsitinib is an experimental ...... nical trials were in progress.
@en
Linsitinib é uma droga experim ...... ra cancer pulmonar e ovariano.
@pt
alternative name
OSI-906
@en
IUPAC name
3-[8-Amino-1-(2-phenyl-7-quinolyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-cyclobutanol
@en
Wikipage page ID
37,339,814
page length (characters) of wiki page
Wikipage revision ID
1,000,023,634
Link from a Wikipage to another Wikipage
ImageFile
@en
imagesize
IUPACName
OtherNames
OSI-906
@en
wikiPageUsesTemplate
subject
hypernym
comment
Linsitinib is an experimental ...... tical carcinoma in March 2012.
@en
Linsitinib é uma droga experim ...... ra cancer pulmonar e ovariano.
@pt
label
Linsitinib
@en
Linsitinib
@pt